https://www.selleckchem.com/pr....oducts/solutol-hs-15
Future studies should consider the identification of the new pathophysiological targets and high-quality translational research should facilitate incorporation of more targeted interventions in clinical research protocols, aimed to improve individual patient outcomes. Designing outcome clinical trials in CS remains particularly challenging in this critical and very costly scenario in cardiology, but information from these trials is imperiously needed to better inform the guidelines and clinical practice. The goal of this review is
Synes godt om
Kommentar
Del
